Alsoufi Bahaaldin, Rao Vivek, Tang Augustine, Maganti Manjula, Cusimano Robert
Division of Cardiovascular Surgery, Toronto General Hospital and the University of Toronto, Toronto, Ontario, Canada.
J Saudi Heart Assoc. 2012 Apr;24(2):69-72. doi: 10.1016/j.jsha.2012.02.005. Epub 2012 Feb 13.
Post-cardiotomy shock (PCS) has a complex etiology. Although treatment with inotrops and intra-aortic balloon pump (IABP) support improves cardiac performance, end-organ injuries are common and lead to prolonged ICU stay, extended hospitalization and increased mortality. Early consideration of mechanical circulatory support may prevent such complications and improve outcome.
Between January 1997 and January 2002, 321 patients required IABP and inotropic support for PCS following coronary artery bypass grafting (CABG) at our institution. Perioperative variables including age, mixed venous saturation (MVO2), inotropic requirements and LV function were analyzed using multivariate statistical methods. All explanatory variables with a univariate p value <0.10 were entered into a stepwise logistic regression model to predict hospital mortality. Odds ratios from significant variables (p < 0.05) in the regression model were used to compose a risk score.
Overall hospital mortality was 16%. The independent risk factors for mortality in this population were: MVO2 < 60% (OR = 3.2), milrinone > 0.5 μg/kg/min (OR = 3.2), age > 75 (OR = 2.7), adrenaline > 0.1 μg/kg/min (OR = 1.5). A 15-point risk score was developed based on the regression model. Hospital mortality in patients with a score >6 was 46% (n = 13/28), 3-6 was 31% (n = 9/29) and <3 was 11% (n = 29/264).
A significant proportion of patients with PCS continue to face high mortality despite IABP and inotropic support. Advanced age, heavy inotropic dependency and poor oxygen delivery all predicted increased risk for death. Further investigation is needed to assess whether early institution of VAD support could improve outcome in this high-risk group of patients.
心脏术后休克(PCS)病因复杂。尽管使用血管活性药物和主动脉内球囊反搏(IABP)支持治疗可改善心脏功能,但多器官损伤常见,会导致重症监护病房(ICU)住院时间延长、住院时间延长及死亡率增加。早期考虑机械循环支持可能预防此类并发症并改善预后。
1997年1月至2002年1月期间,我院321例冠状动脉旁路移植术(CABG)后因PCS需要IABP和血管活性药物支持的患者。使用多变量统计方法分析围手术期变量,包括年龄、混合静脉血氧饱和度(MVO2)、血管活性药物需求和左心室功能。将所有单变量p值<0.10的解释变量纳入逐步逻辑回归模型以预测医院死亡率。回归模型中显著变量(p<0.05)的比值比用于构成风险评分。
总体医院死亡率为16%。该人群死亡的独立危险因素为:MVO2<60%(比值比=3.2)、米力农>0.5μg/kg/min(比值比=3.2)、年龄>75岁(比值比=2.7)、肾上腺素>0.1μg/kg/min(比值比=1.5)。基于回归模型制定了一个15分的风险评分。评分>6分的患者医院死亡率为46%(n=13/28),3-6分的为31%(n=9/29),<3分的为11%(n=29/264)。
尽管有IABP和血管活性药物支持,仍有相当比例的PCS患者面临高死亡率。高龄、对血管活性药物高度依赖和氧输送不足均预示死亡风险增加。需要进一步研究以评估早期应用心室辅助装置(VAD)支持是否能改善这一高危患者群体的预后。